Retatrutide is getting a lot of attention
At Cape Fear Physical Medicine and Rehab, we can integrate medical weight managementincluding the use of GLP-1 agonists like Ozempicinto individualized treatment plans to support long-term functional improvement and pain relief
Why Understanding GLP-1 Science Matters for Your Weight Management Many weight loss failures stem from fighting your body's natural hunger machinery rather than optimizing it
Understanding this triple mechanism is essential for anyone researching the best peptides for weight loss
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
Monitoring Your Health During Extended Use Year-round use of any medication warrants regular health check-ins
